NCCN Guideline Concordance Improves Survival in Pediatric and Young Adult Rectal Cancer

Colleen P Nofi1, Sara Siskind2, Gary B Deutsch3

  • 1Cohen Children's Medical Center, Division of Pediatric General, Thoracic, and Endoscopic Surgery, 269-01 76th Avenue, Queens NY 11040, USA; Northwell North Shore/Long Island Jewish, Department of Surgery, 300 Community Drive, Manhasset NY 11030, USA.

PubMed

Insights

Management guidelines for pediatric and young adult rectal cancer are lacking. Adhering to National Comprehensive Cancer Network (NCCN) guidelines for rectal cancer improves survival in these young patients.

Area of Science:

  • Oncology
  • Clinical Research
  • Cancer Management

Background:

  • No established management guidelines exist for pediatric and young adult rectal cancer.
  • Adult rectal cancer management guidelines are well-documented, but a gap exists for younger populations.

Purpose of the Study:

  • To evaluate the adherence to National Comprehensive Cancer Network (NCCN) guidelines in pediatric and young adult rectal cancer patients.
  • To assess the impact of guideline-concordant therapy on survival outcomes in these patient groups.

Main Methods:

  • Retrospective analysis of the National Cancer Database (2004-2018).
  • Inclusion of pediatric (0-21 years) and young adult (22-40 years) patients diagnosed with rectal cancer.
  • Evaluation of pre-operative and post-operative guideline concordance and its correlation with survival using Cox regression and Kaplan-Meier analysis.

Main Results:

  • 89.6% of pediatric and 84.6% of young adult patients received pre-operative guideline-concordant therapy.
  • Pediatric patients were less likely to receive post-operative guideline-concordant therapy compared to young adults (65.3% vs. 76.7%).
  • Guideline-concordant therapy significantly reduced the risk of death in both pediatric and young adult rectal cancer patients.

Conclusions:

  • National Comprehensive Cancer Network (NCCN)-based guidelines can effectively guide peri-operative management and enhance survival in pediatric and young adult rectal cancer.
  • Due to the rarity of rectal cancer in young patients, a multidisciplinary team approach and patient/family involvement are crucial for optimal treatment strategies.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
241
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K